Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Miscellaneous non-inflammatory musculoskeletal conditions. Blau syndrome.

Punzi L, Gava A, Galozzi P, Sfriso P.

Best Pract Res Clin Rheumatol. 2011 Oct;25(5):703-14. doi: 10.1016/j.berh.2011.10.017. Review.

PMID:
22142748
2.

Blau syndrome, clinical and genetic aspects.

Sfriso P, Caso F, Tognon S, Galozzi P, Gava A, Punzi L.

Autoimmun Rev. 2012 Nov;12(1):44-51. doi: 10.1016/j.autrev.2012.07.028. Epub 2012 Aug 2. Review.

PMID:
22884558
3.

[Mutations of NOD2 gene and clinical features in Chinese Blau syndrome patients].

Wang W, Wei M, Song H, Qiu Z.

Zhonghua Er Ke Za Zhi. 2014 Dec;52(12):896-901. Chinese.

PMID:
25619344
4.

Blau syndrome and latent tubercular infection: an unresolved partnership.

Caso F, Wouters CH, Rose CD, Costa L, Tognon S, Sfriso P, Cantarini L, Rigante D, Punzi L.

Int J Rheum Dis. 2014 Jun;17(5):586-7. doi: 10.1111/1756-185X.12330. Epub 2014 Mar 20. No abstract available.

PMID:
24646037
5.

NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort.

Aróstegui JI, Arnal C, Merino R, Modesto C, Antonia Carballo M, Moreno P, García-Consuegra J, Naranjo A, Ramos E, de Paz P, Rius J, Plaza S, Yagüe J.

Arthritis Rheum. 2007 Nov;56(11):3805-13.

6.

Blau syndrome.

Martin J, Kodjikian L, Duquesne A, Le Scanff J, Sève P.

QJM. 2011 Nov;104(11):997-8. doi: 10.1093/qjmed/hcq188. Epub 2010 Oct 13. No abstract available.

PMID:
20947513
7.

Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis.

Caso F, Costa L, Rigante D, Vitale A, Cimaz R, Lucherini OM, Sfriso P, Verrecchia E, Tognon S, Bascherini V, Galeazzi M, Punzi L, Cantarini L.

Autoimmun Rev. 2014 Dec;13(12):1220-9. doi: 10.1016/j.autrev.2014.08.010. Epub 2014 Aug 23. Review.

PMID:
25182201
8.

Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes.

Rosé CD, Pans S, Casteels I, Anton J, Bader-Meunier B, Brissaud P, Cimaz R, Espada G, Fernandez-Martin J, Hachulla E, Harjacek M, Khubchandani R, Mackensen F, Merino R, Naranjo A, Oliveira-Knupp S, Pajot C, Russo R, Thomée C, Vastert S, Wulffraat N, Arostegui JI, Foley KP, Bertin J, Wouters CH.

Rheumatology (Oxford). 2015 Jun;54(6):1008-16. doi: 10.1093/rheumatology/keu437. Epub 2014 Nov 20.

PMID:
25416713
9.

Uveitis in Blau syndrome from a de novo mutation of the NOD2/CARD15 gene.

Raiji VR, Miller MM, Jung LK.

J AAPOS. 2011 Apr;15(2):205-7. doi: 10.1016/j.jaapos.2011.02.004.

PMID:
21596301
10.

Blau syndrome-associated uveitis and the NOD2 gene.

Pillai P, Sobrin L.

Semin Ophthalmol. 2013 Sep-Nov;28(5-6):327-32. doi: 10.3109/08820538.2013.825285. Epub 2013 Sep 6. Review.

PMID:
24010719
11.

Clinical and genetic aspects of Blau syndrome: a 25-year follow-up of one family and a literature review.

Punzi L, Furlan A, Podswiadek M, Gava A, Valente M, De Marchi M, Peserico A.

Autoimmun Rev. 2009 Jan;8(3):228-32. doi: 10.1016/j.autrev.2008.07.034. Epub 2008 Aug 19.

12.

[Early-onset sarcoidosis/Blau syndrome].

Kambe N, Satoh T, Nakano M, Nakamura Y, Matsue H.

Nihon Rinsho Meneki Gakkai Kaishi. 2011;34(5):378-81. Review. Japanese.

13.

Sporadic Blau syndrome with onset of widespread granulomatous dermatitis in the newborn period.

Stoevesandt J, Morbach H, Martin TM, Zierhut M, Girschick H, Hamm H.

Pediatr Dermatol. 2010 Jan-Feb;27(1):69-73. doi: 10.1111/j.1525-1470.2009.01060.x.

PMID:
20199415
14.

Morphologic and immunohistochemical characterization of granulomas in the nucleotide oligomerization domain 2-related disorders Blau syndrome and Crohn disease.

Janssen CE, Rose CD, De Hertogh G, Martin TM, Bader Meunier B, Cimaz R, Harjacek M, Quartier P, Ten Cate R, Thomee C, Desmet VJ, Fischer A, Roskams T, Wouters CH.

J Allergy Clin Immunol. 2012 Apr;129(4):1076-84. doi: 10.1016/j.jaci.2012.02.004.

PMID:
22464675
15.

[Clinical features of Blau syndrome and early-onset sarcoidosis and associating CARD15/NOD2 gene mutations].

Kanazawa N.

Nihon Rinsho Meneki Gakkai Kaishi. 2007 Apr;30(2):123-32. Japanese.

16.

A case of infantile Takayasu arteritis with a p.D382E NOD2 mutation: an unusual phenotype of Blau syndrome/early-onset sarcoidosis?

Inoue Y, Kawaguchi Y, Shimojo N, Yamaguchi K, Morita Y, Nakano T, Arima T, Tomiita M, Kohno Y.

Mod Rheumatol. 2013 Jul;23(4):837-9. doi: 10.1007/s10165-012-0720-z. Epub 2012 Jul 21.

PMID:
22821420
17.

Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis.

Okafuji I, Nishikomori R, Kanazawa N, Kambe N, Fujisawa A, Yamazaki S, Saito M, Yoshioka T, Kawai T, Sakai H, Tanizaki H, Heike T, Miyachi Y, Nakahata T.

Arthritis Rheum. 2009 Jan;60(1):242-50. doi: 10.1002/art.24134.

18.

[The present and the prospect of study on Blau syndrome/early-onset sarcoidosis].

Nakano M, Kambe N.

Nihon Rinsho. 2013 Apr;71(4):737-41. Review. Japanese.

PMID:
23678609
19.

Immunohistochemical evidence of specific iris involvement in Blau syndrome.

Paparizos SC, Goldstein DA, Bouhenni RA, Steiner S, Dunmire JJ, Edward DP.

Ocul Immunol Inflamm. 2012 Dec;20(6):471-4. doi: 10.3109/09273948.2012.726391.

PMID:
23215732
20.

NOD2/CARD15 gene mutation identified in a Chinese family with Blau syndrome.

Xiang H, Zhang T, Chen M, Zhou X, Li Z, Yan N, Li S, Han Y, Gong Q, Liu X.

Mol Vis. 2012;18:617-23. Epub 2012 Mar 9.

Supplemental Content

Support Center